Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Samil Pharm (000520)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
9,230 0    0.00%
02/05 - Closed. Currency in KRW ( Disclaimer )
  • Volume: 140,067
  • Bid/Ask: 9,210 / 9,230
  • Day's Range: 9,090 - 9,360
Type:  Equity
Market:  South Korea
ISIN:  KR7000520007 
Samil Pharm 9,230 0 0.00%

000520 Balance Sheet

 
Featured here, the Balance Sheet for Samil Pharm, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Current Assets 81115.09 91632.38 84762.18 75591.55
Cash and Short Term Investments 906.14 9600.66 1985.35 3046.47
Cash - - - -
Cash & Equivalents 906.14 9600.66 1985.35 3046.47
Short Term Investments - - - -
Total Receivables, Net 35900.06 37856.94 34568.4 34335.87
Accounts Receivables - Trade, Net 35813.44 37741.37 34480.36 34270.77
Total Inventory 32511.41 31562.89 34141.35 23197.45
Prepaid Expenses - 11577.89 11803.94 11560.89
Other Current Assets, Total 11797.48 1034 2263.13 3450.88
Total Assets 370680.1 383180.12 372368.19 359895.87
Property/Plant/Equipment, Total - Net 242198.5 243634.31 239611.17 236785.51
Property/Plant/Equipment, Total - Gross 297606.79 297959.78 293081.95 289205.09
Accumulated Depreciation, Total -55408.3 -54325.47 -53470.79 -52419.58
Goodwill, Net - - - -
Intangibles, Net 1916.58 2142.52 2223.11 2283.78
Long Term Investments 797.39 752.92 705.63 781.2
Note Receivable - Long Term 86.62 115.57 88.05 65.1
Other Long Term Assets, Total 43750.5 44233.81 44320.15 43688.41
Other Assets, Total 9310.87 -4475.88 2582.04 -6922.12
Total Current Liabilities 168674.68 159911.03 162748.58 157469.08
Accounts Payable 21003.67 23605.04 27072.6 11407.22
Payable/Accrued - - - -
Accrued Expenses 3282.28 3799.7 4006.43 3643.41
Notes Payable/Short Term Debt 73490 86524.28 81830 83681.74
Current Port. of LT Debt/Capital Leases 51595.5 28972.42 28270.35 29015.14
Other Current liabilities, Total 19303.23 17009.59 21569.19 29721.58
Total Liabilities 242852.73 250494.29 239414.21 230597
Total Long Term Debt 50793.65 69569.27 56201.7 47084.8
Long Term Debt 49568.46 68269.82 54895.32 45755.56
Capital Lease Obligations 1225.19 1299.46 1306.38 1329.24
Deferred Income Tax 9752.08 10967.64 10967.64 13579.01
Minority Interest - - - -
Other Liabilities, Total -59857.69 -76477.92 -72333.71 -71217.63
Total Equity 127827.37 132685.83 132953.99 129298.87
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 7613.39 7613.39 7504.88 6857.22
Additional Paid-In Capital 44007.61 44007.66 42525.46 40476.61
Retained Earnings (Accumulated Deficit) 28018.58 28555.98 29270.77 28998.2
Treasury Stock - Common -4160.76 -4160.76 -4160.76 -4142.2
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 52348.54 56669.55 57813.63 57109.04
Total Liabilities & Shareholders' Equity 370680.1 383180.12 372368.19 359895.87
Total Common Shares Outstanding 14.46 14.46 14.25 14.25
Total Preferred Shares Outstanding - - - -
* In Millions of KRW (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

000520 Comments

Write your thoughts about Samil Pharm
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email